ZyVersa Therapeutics, Inc.
ZVSA· OTC
ZVSAZyVersa Therapeutics, Inc.
Filed Mar 31, 2023 · 10-K · 109 days after period end · 0001493152-23-010259
derived · Computed from the longer spans the company filed.
no prior Q4 2021 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 12, 2022 · filed Mar 31, 2023 · 109 d after period end
ZyVersa Therapeutics, Inc. · CIK 1859007 · Engraved from SEC EDGAR
